SurModics, Inc. (NASDAQ:SRDX)

CAPS Rating: 2 out of 5

Develops, manufactures and markets innovative surface modification and drug delivery technologies for the healthcare industry.

Recs

0
Player Avatar paggles (77.84) Submitted: 2/14/2009 2:25:27 AM : Outperform Start Price: $18.99 SRDX Score: -91.73

Well positioned for growth in healthcare sector. Could be bought by major drug company by the end of 2009. Several things to like for the beaten down price

Featured Broker Partners


Advertisement